Aplasia cutis congenita after exposure to methimazole: a causal relationship?
We report a child with scalp aplasia cutis congenita, whose mother was treated with methimazole during pregnancy. The relationship between antithyroid drug administration during pregnancy and the occurrence of scalp defects is discussed, and the pertinent literature is reviewed.
Vogt
T
T
Department of Dermatology, University of Regensburg, Germany.
Stolz
W
W
Landthaler
M
M
D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects*; D004476:Ectodermal Dysplasia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008713:Methimazole / Q000009:adverse effects*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012536:Scalp Dermatoses / Q000139:chemically induced*
D013956:Antithyroid Agents; D008713:Methimazole